Patent · US Expired

Therapeutic targets in cancer

US7767387B2 · kind B2 · utility

1Cited by
64References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 13, 2003
Grant dateAug 3, 2010
Priority date
Expiry dateApr 2, 2026

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/25
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to novel sequences for use in detection, diagnosis and treatment of cancers, especially lymphomas. The invention provides cancer-associated (CA) polynucleotide sequences whose expression is associated with cancer. The present invention provides CA polypeptides associated with cancer that are present on the cell surface and present novel therapeutic targets against cancer. The present invention further provides diagnostic compositions and methods for the detection of cancer. The present invention provides monoclonal and polyclonal antibodies specific for the CA polypeptides. The present invention also provides diagnostic tools and therapeutic compositions and methods for screening, prevention and treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.